. . . . . . . . . . . . . . . "a(CHEBI:lipopolysaccharide) -> kin(p(HGNC:IRAK4))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Exposure to TLR4 antibody, TLR4 siRNA, or an IRAK-1/4 inhibitor eliminated the LPS-induced increases in Bcl10, NF-kappaB, and IL-8." . . "Selventa" . . . . "2014-07-03T14:33:10.814+02:00"^^ . . .